A modest increase in protein content and a modest decrease in glycemic index values allowed study subjects to maintain a 10-kg weight loss better than did other dietary manipulations, according to a randomized trial reported in the Nov. 25 issue of the New England Journal of Medicine.
Provectus Pharmaceuticals announced on Nov. 23 that it has enrolled at least 40 patients in its compassionate use program for PV-10, an experimental drug being studied primarily for melanoma.
DENVER (EGMN) A once-daily combination of ezetimibe 10 mg and simvastatin 20 mg reduced the risk of major atherosclerotic events in patients with chronic kidney disease by 16.5%, according to a randomized, placebo-controlled trial funded by the drugs maker, Merck.
Propoxyphene, a widely used treatment for mild to moderate pain, has been removed from the U.S. market due to an increased risk of serious fatal heart rhythm abnormalities in people taking the drug, Food and Drug Administration officials said Nov. 19.
COLLEGE PARK, Md. (EGMN) A Food and Drug Administration advisory panel on Nov. 18 split on whether to support approval of a noninvasive device intended to help physicians detect early melanomas.
Adults in the United States are far more likely than those in 10 other countries to go without health care due to cost, have difficulty paying their medical bills, and have disputes with their insurers over bills, according to a new 11-country survey published Nov. 18.
ADELPHI, MD. Belimumab should be approved for reducing disease activity in adults with active autoantibodypositive systemic lupus erythematosus who are on standard treatment, a Food and Drug Administration advisory panel recommended in a 13-2 vote.
A aimed at improving the reliability of external defibrillators has been launched by the Food and Drug Administration, the agency announced Nov. 15.
A large, retrospective cohort study published Nov. 12 in BMJ is the latest to look at the association between isotretinoin and attempted suicide. Concerns about a link between isotretinoin and suicidal behavior have abounded for years, although previous studies have failed to show a conclusive link.
Children at risk for type 1 diabetes showed fewer signs of beta-cell autoimmunity for up to 10 years if they were fed a highly hydrolyzed casein formula rather than conventional cows-milkbased formula during infancy, according to a report in the Nov. 11 issue of the New England Journal of Medicine.
